WT1 and acute myeloid leukemia: Using doses of VEN that increased DNT cytotoxicity in a prior report (100 nM and 200 nM), we observed minimally increased cytotoxicity with VEN-pretreatment of the WT1-CTLs from multiple donors on all 3 AML cell lines (Fig. 4B, Supplementary Fig. 3B) [29].